Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Sweden Point of Care Diagnostics Market: By Product Type, By End User, and Country
Sweden Point of Care Diagnostics Market: By Product Type, By End User, and Country
Sweden Point of Care Diagnostics Market size was valued at US$ 39.4 million in 2023 and is poised to grow at 5.1% CAGR during 2024-2030. Point of Care Diagnostics are medical diagnostic tests conducted at or near the site of patient care. In contrast, traditional laboratory testing requires the dispatch of samples for analysis; this waits longer to return the results. PoC diagnostics immediately provide the result, which can facilitate quicker clinical decisions, especially in life-threatening situations and chronic illness management, and in remote areas where healthcare resources are distant. Other common tests carried out at a PoC include: glucose testing, pregnancy testing, blood gas testing, and rapid testing for infectious diseases.
The Point of Care Diagnostics market in Sweden is part of the larger European PoC market and is characterized by the adoption of advanced diagnostic technologies, a strong healthcare infrastructure, and a focus on preventive care. The market is driven by the increasing prevalence of chronic diseases, the need for rapid diagnostic results, and a growing aging population. For instance, Sweden has one of the oldest populations in Europe, with a median age of 41.1 years as of 2024. This demographic shift increases the demand for PoC diagnostics, particularly for managing chronic conditions like diabetes and cardiovascular diseases. Whereas, stringent regulatory requirements for the approval of new PoC diagnostic devices can delay their market entry, affecting the pace of innovation and adoption. However, the integration of AI and IoT in PoC devices is expected to enhance diagnostic accuracy and patient monitoring, presenting significant growth opportunities in the Swedish market.
In the PoC Diagnostics market, high prevalence of chronic diseases such as diabetes and cardiovascular conditions is one of the major driving forces. According to an estimate of the Swedish National Board of Health and Welfare, approximately 7% of the population were suffering from diabetes in 2022 in Sweden. These growing cases require regular monitoring with rapid diagnostic results, hence making PoC diagnostics an essential tool in the management of such diseases. Applications, such as some of the various glucose monitoring devices utilized in diabetic care, allow patients to better manage their disease states outside the demand on time within healthcare settings. Additionally, the Swedish healthcare system's emphasis on decentralized healthcare and patient-centred care also supports the expansion of the PoC diagnostics market. For instance, the Swedish government is known for its high healthcare spending, which was around 11% of GDP in 2022. This investment supports the adoption of advanced diagnostic tools, including PoC devices, in both primary and secondary healthcare settings.
|
Report Benchmarks |
Details |
|
Market Size in 2023 |
US$ 39.4 million |
|
By Product Type |
|
|
By End User |
|
Download Free Sample Report
The Sweden point-of-care diagnostics market size was valued at US$ 39.4 million in 2023 and is projected to grow at a CAGR of 5.1% from 2024-2030.
Point of Care Diagnostics involves medical testing conducted near the patient, allowing for immediate results and quicker clinical decision-making.
Key drivers include an aging population, the rising prevalence of chronic diseases, and government investments in healthcare.
The Stockholm region leads the market due to its advanced healthcare infrastructure, high patient awareness, and significant healthcare investments.
1. Executive Summary
2. Sweden Point of Care Diagnostics Introduction
2.1. Sweden Point of Care Diagnostics - Taxonomy
2.2. Sweden Point of Care Diagnostics - Definitions
2.2.1. Product Type
2.2.2. End User
3. Sweden Point of Care Diagnostics Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Key Developments
3.6. Epidemiology
4. Sweden Point of Care Diagnostics By Product Type, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
4.1. Infectious Disease Testing Kits
4.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
4.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.1.3. Market Opportunity Analysis
4.2. Cardio-Metabolic Monitoring Kits
4.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
4.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.2.3. Market Opportunity Analysis
4.3. COVID-19 Testing Kits
4.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
4.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.3.3. Market Opportunity Analysis
4.4. Hematological Testing Kits
4.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
4.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.4.3. Market Opportunity Analysis
4.5. Fecal Occult Testing Kits
4.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
4.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.5.3. Market Opportunity Analysis
4.6. Glucose Monitoring Kits
4.6.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
4.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.6.3. Market Opportunity Analysis
4.7. Cholesterol Test Strips
4.7.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
4.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.7.3. Market Opportunity Analysis
4.8. Urinalysis Testing Kits
4.8.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
4.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.8.3. Market Opportunity Analysis
4.9. Others
4.9.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
4.9.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.9.3. Market Opportunity Analysis
5. Sweden Point of Care Diagnostics By End User, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
5.1. Private Labs
5 1 1 Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Public Labs
5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Homecare
5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Others
5.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
6. Competition Landscape
6.1. Strategic Dashboard of Top Market Players
6.2. Company Profiles (Introduction, Financial Analysis, By Product Offerings, Key Developments, Strategies, and SWOT Analysis)
6.2.1. Siemens Healthneers
6.2.2. Roche Diagnostics
6.2.3. Abbott Laoratories
6.2.4. Becton, Dickinson, and Company
6.2.5. Beckman Coulter, Inc.
6.2.6. Company 6
6.2.7. Company 7
6.2.8. Company 8
6.2.9. Company 9
6.2.10. Company 10
7. Research Methodology
8. Key Assumptions and Acronyms
Key Market Players
• Siemens Healthneers
• Roche Diagnostics
• Abbott Laoratories
• Becton, Dickinson, and Company
• Beckman Coulter, Inc.
• Company 6
• Company 7
• Company 8
• Company 9
• Company 10
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.